查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1622107

心臟修復系統的全球市場規模:各產品，各用途，各終端用戶，各地區，範圍及預測

Global Cardiac Restoration Systems Market Size By Product, By Application, By End-User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

心臟修復系統的市場規模與預測

心臟修復系統市場規模近年來以顯著的成長率快速成長，市場估計與預測預計2019年至2026年將大幅成長。

心臟相關疾病的增加促進了市場的成長。全球心臟修復系統市場報告提供了對市場的整體評估。它對關鍵細分市場、趨勢、市場驅動因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

全球心臟修復系統市場的定義

與心臟相關的疾病是世界多個地區的主要原因。人們接受手術是為了改善心臟狀況。心臟修復系統在冠狀動脈繞道、二尖瓣修復、冷凍消融和心內膜切除術後進行。二尖瓣修復和左心室修復是心臟修復系統的兩個應用。左心室心臟修復系統是一種不同於傳統外科重建方法的微創方法。這些修復系統在醫院和門診手術中心提供。

心臟修復系統的全球市場概況

本報告的市場展望部分主要涵蓋市場的基本動態，包括市場面臨的驅動因素、阻礙因素、機會和課題。市場推動因素和阻礙因素是內在因素，市場推動因素/課題是外在因素。

心臟相關疾病的增加促進了市場的成長。由於生活方式的改變，心臟病患者的數量不斷增加。醫療保健領域不斷增加的資金和技術創新正在推動市場發展。肥胖率的加速和老年人口的不斷增長正在顯著促進市場成長。然而，這些修復系統價格昂貴，這可能會影響市場成長。

經過驗證的市場研究使用主要資訊來縮小可用數據範圍、驗證數據並編制全面的市場研究報告。該研究報告包括對客戶感興趣的市場因素的定量和定性估計。 "全球心臟修復系統市場" 主要分為幾個子部分，可以提供有關市場最新發展的分類資料。

目錄

第1章 心臟修復系統的全球市場:簡介

  • 市場概要
  • 調查範圍
  • 前提條件

第2章 摘要整理

第3章 VERIFIED MARKET RESEARCH的調查手法

  • 資料探勘
  • 驗證
  • 一次採訪
  • 資料來源一覽

第4章 心臟修復系統的全球市場展望

  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 波特的五力分析
  • 價值鏈分析

第5章 心臟修復系統的全球市場:各產品

  • 概要
  • 二尖瓣修復系統
  • 左心室修復系統

第6章 心臟修復系統的全球市場:各用途

  • 概要
  • 經皮心室修復
  • 外科手術的心室修復

第7章 心臟修復系統的全球市場:各終端用戶

  • 概要
  • 門診外科醫院
  • 診療所
  • 其他

第8章 心臟修復系統的全球市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 全球其他地區
    • 南美
    • 中東·非洲

第9章 全球心臟修復系統市場:競爭情形

  • 概要
  • 企業的市場排行榜
  • 主要的發展策略

第10章 企業簡介

  • Abbott Laboratories
  • BioVentrix Inc.
  • Edwards Lifesciences Corp.
  • CryoLife Inc.
  • Xeltis AG
  • NeoChord Inc.

第11章 附錄

  • 相關調查
簡介目錄
Product Code: 15379

Cardiac Restoration Systems Market Size And Forecast

Cardiac Restoration Systems Market size is growing at a faster pace with substantial growth rates over the last few years and is estimated that the market will grow significantly in the forecasted period i.e. 2019 to 2026.

The Growing incidences of heart-related disorders have helped in market growth. The Global Cardiac Restoration Systems Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cardiac Restoration Systems Market Definition

Heart-related disorders are prominent causes of death in several parts of the world. People undergo surgeries to attain better heart conditions. Cardiac Restoration Systems are done after a coronary artery bypass, mitral valve repair, cryoablation, and endocardectomy. Mitral valve restoration and left ventricular restoration are the two applications of cardiac restoration systems. The left ventricular cardiac restoration system is different from the conventional surgical reconstructive approach and is a less invasive approach. These restoration systems are provided by hospitals and ambulatory surgical centers.

Global Cardiac Restoration Systems Market Overview

In the report, the market outlook section mainly encompasses the fundamental dynamics of the market which include drivers, restraints, opportunities, and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.

The Growing incidences of heart-related disorders have helped in market growth. Change in lifestyle patterns has raised the number of patients with heart disorders. Increased funding in the healthcare sector and technological innovation are driving the market forward. The rising pace of obesity and the growing sector of the geriatric population is improving market growth significantly. However, these restoration systems come with a heavy price and may affect market growth.

Verified Market Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The "Global Cardiac Restoration Systems Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.

Global Cardiac Restoration Systems Market: Segmentation Analysis

The Global Cardiac Restoration Systems Market is Segmented on the basis of Product, Application, End-User, And Geography.

Cardiac Restoration Systems Market, By Product

  • Mitral Valve Restoration System
  • Left Ventricular Restoration System

Based on Product, the market is segmented into Mitral Valve Restoration System and Left Ventricular Restoration System.

Cardiac Restoration Systems Market, By Application

  • Percutaneous Ventricular Restoration
  • Surgical Ventricular Restoration

Based on Application, the market is segmented into Percutaneous Ventricular Restoration and Surgical Ventricular Restoration.

Cardiac Restoration Systems Market, By End-User

  • Hospitals
  • Ambulatory Surgical Clinics
  • Others

Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Clinics, and Others.

Cardiac Restoration Systems Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global Cardiac Restoration Systems Market is classified into North America, Europe, Asia Pacific, and the Rest of the world.

Key Players

  • The "Global Cardiac Restoration Systems Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as
  • Abbott Laboratories, BioVentrix Inc., Edwards Lifesciences Corp., CryoLife Inc., Xeltis AG, And NeoChord Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARDIAC RESTORATION SYSTEMS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CARDIAC RESTORATION SYSTEMS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CARDIAC RESTORATION SYSTEMS MARKET, BY PRODUCT

  • 5.1 Overview
  • 5.2 Mitral Valve Restoration System
  • 5.3 Left Ventricular Restoration System

6 GLOBAL CARDIAC RESTORATION SYSTEMS MARKET, BY APPLICATION

  • 6.1 Overview
  • 6.2 Percutaneous Ventricular Restoration
  • 6.3 Surgical Ventricular Restoration

7 GLOBAL CARDIAC RESTORATION SYSTEMS MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Ambulatory Surgical Hospitals
  • 7.3 Clinics
  • 7.4 Others

8 GLOBAL CARDIAC RESTORATION SYSTEMS MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL CARDIAC RESTORATION SYSTEMS MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Abbott Laboratories
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 BioVentrix Inc.
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Edwards Lifesciences Corp.
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 CryoLife Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Xeltis AG
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 NeoChord Inc.
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments

11 Appendix

  • 11.1 Related Research